What You Should Know
The Raise: Worki, a healthcare workforce infrastructure company, has announced a $2.75M pre-seed funding round led by healthcare venture builder Redesign Health, alongside Healthliant Ventures (Tanner Health’s venture arm).The Solution: Worki is an AI-native infrastructure layer that sits between the systems hospitals already use (like Workday, UKG, Oracle, and ServiceNow). It unifies workforce data to create a "connective tissue" across the enterprise.Task-Role
Read More
Archives for 2026
ARC Launches ‘ARC Landing Boston’ Healthtech Accelerator with Massachusetts Governor Maura Healey
What You Should Know
The Launch: ARC (the innovation arm of Israel's Sheba Medical Center) has officially launched ARC Landing Boston in partnership with the administration of Massachusetts Governor Maura Healey.The Mission: The accelerator serves as a "soft-landing" platform for global healthtech companies attempting to enter the notoriously complex U.S. market, providing direct access to clinical environments, regulatory support, and venture capital.The Inaugural Cohort: The accelerator is
Read More
Walmart Expands Better Care Services Platform with GLP-1 Weight Management Offerings
What You Should Know
The Expansion: Walmart is heavily expanding its digital health platform, Better Care Services, to include comprehensive weight management support for customers exploring or currently taking GLP-1 therapies.The Digital Health Bundle: The retail giant is acting as a centralized hub, partnering with third-party digital health companies including Aaptiv (fitness), Berry Street (registered dietitians), Curai Health (AI-supported coaching), MyCare by Twin Health (metabolic
Read More
Wegovy HD Now Available on GoodRx for $399 Per Month Self-Pay
What You Should Know
The Launch: GoodRx has announced it is now offering Wegovy HD—Novo Nordisk’s newly introduced, higher-dose (7.2 mg) semaglutide injection.The Price Point: In a major move for the direct-to-consumer market, the medication is available to eligible self-pay patients at a transparent price of $399 per month. Pricing scales predictably to $798 for a two-month supply and $1,197 for a three-month supply.The Clinical Strategy: Wegovy HD serves as an FDA-approved "step-up" option
Read More
M&A: D2 Solutions Acquires ProModRx to Streamline Patient Journeys
What You Should Know
The Acquisition: D2 Solutions, a healthcare consulting and technology company focused on market access, has officially acquired ProModRx, a cloud-based technology platform designed to accelerate patient access to prescription medications. Financial details of the acquisition were not disclosed. The Core Problem: The prescription fulfillment pipeline is fundamentally broken. According to D2's internal research, 21% of adults delayed starting a prescribed medication because
Read More
How Pharma Commercial Teams Should Plan Their 2026 Oncology Event Strategy
Given the highly targeted nature of the cancer treatment, most Pharma companies target all their HTA activity on oncology; most, if not all, of their promotional budget on oncology spends go toward conferences and major Oncology events, which serve as the primary interface and promotional activity with target customers, decision makers, and influencers.
Not only do Pharma companies need to simultaneously invest hundreds of thousands of promotional budget dollars on competing mega-events, but
Read More
Why Abridge is Embedding NEJM and JAMA Directly into the EHR
What You Should Know
The Partnerships: Enterprise AI platform Abridge has secured multi-year content partnerships with the NEJM Group (publisher of the New England Journal of Medicine) and the American Medical Association (publisher of the JAMA Network).The Workflow Shift: The integration allows clinicians to ask complex clinical questions and receive evidence-based answers directly within their existing workflow. Historically, finding this literature required breaking focus, leaving the EHR,
Read More
Sonire Therapeutics Raises $18M to Transform Pancreatic Cancer Treatment
What You Should Know
The Raise: Clinical-stage medical device company Sonire Therapeutics has announced an $18M Series A financing round. The round was led by Santé Ventures, with participation from Fast Track Initiative (FTI), Nomura SPARX Investment, and SBI Investment.The Technology: Sonire has developed a proprietary High-Intensity Focused Ultrasound (HIFU) therapy system for the non-invasive thermal ablation of solid tumors.The Clinical Target: The company is initially focusing on
Read More
Osteoboost Health Raises $8M for FDA-Cleared Bone Density Device
What You Should Know
The Raise: Osteoboost Health has closed an $8M financing round led by Ambit Health Ventures, with participation from Emmeline Ventures, Disrupt Health Impact Fund, Esplanade Ventures, and Portfolia.The Device: The FDA-cleared "Osteoboost" device is a wearable belt worn low around the hips. It delivers targeted, precisely calibrated vibration therapy directly to the lumbar spine and hips (the regions most vulnerable to fracture).The Clinical Gap: The device targets
Read More
The Clinical Resolution Gap: Why AI Can’t Fix Broken MSK Care Platforms
For years, clinicians have complained about the same thing: they became doctors to care for patients, not to stare at screens.
The electronic health record inserted a keyboard into the most important relationship in medicine. Now, for the first time in decades, artificial intelligence (AI) is beginning to remove it. Ambient listening technology is giving providers back the focused attention that documentation demands have quietly eroded. That is not a minor workflow improvement. It is a
Read More
